Skip to content

the impact of ChitoHem powder on control of bleeding

Comparing ChitoHem powder and sandbags on control of bleeding after femoral angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017030432858N1
Enrollment
136
Registered
2017-06-01
Start date
2017-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Coronary (artery): atheroma atherosclerosis disease sclerosis

Interventions

Intervention 1: For the ChitoHem group, one gram of ChitoHem powder will be used in the operating room after removing the sheet and the early coagulation will be done manually by the physician to cont
Treatment - Drugs
For the ChitoHem group, one gram of ChitoHem powder will be used in the operating room after removing the sheet and the early coagulation will be done manually by the physician to control bleeding. Th
For the sandbag group, after the removal of the sheet and the early coagulation by hand pressure, the sandbags will be placed at the site of arterial puncture for 6 hours. During this period, the pati

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 20 and 65 years; Full alert; The lack of psychological problems; The lack of an underlying congenital diseases such as hemophilia A, B, and lack of bleeding disorders; Use the right femoral artery; No infection of the groin; Failure to receive anticoagulants; glomerular filtration rate above 50 milligrams per deciliter (due to renal excretion ChitoHem powder); Lack of Vjvdhsasyt to sea; The lack of drug treatment and housing in the past 12 hours. Exclusion criteria: active bleeding from the angiography before removing the sheath; Hold the sheet in position for the next treatment; blood pressure Over 190 or diastolic higher than 110 mm Hg;There is a problem or incident that causes a lack of cooperation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemostasis Time. Timepoint: First time, second time, third time, fourth time, five time, six time, Seventh time Eight time, Twenty-fourth time. Method of measurement: Check list, in which the hematoma size using a flexible ruler is measured and recorded. Time measuring hemostasis using the stopwatch, measuring the amount of bleeding by counting gases, covered in blood, measured pain using a numeric scale of pain numeric Rating Scale( NRS) and data on vital signs with a stethoscope and thermometer , systolic and diastolic blood pressure, height and weight scales with stadiometer with a mercury sphygmomanometer will be registered in the Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Hajizadeh

Ahvaz Jundishapur University of Medical Sciences-school of Nursing

Shahlahajizadeh53@gmail.com+98 61 3161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026